Syndax Pharmaceuticals
SNDX
SNDX
72 hedge funds and large institutions have $244M invested in Syndax Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 28 increasing their positions, 19 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
0.88% less ownership
Funds ownership: 70.41% → 69.53% (-0.88%)
10% less funds holding
Funds holding: 80 → 72 (-8)
53% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 15
Holders
72
Holding in Top 10
2
Calls
$635K
Puts
$397K
Top Buyers
| 1 | +$4.27M | |
| 2 | +$4.03M | |
| 3 | +$3.17M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$2.47M |
| 5 |
BlackRock
New York
|
+$1.81M |
Top Sellers
| 1 | -$4.65M | |
| 2 | -$2.49M | |
| 3 | -$2.03M | |
| 4 |
HIM
Hillhouse Investment Management
Grand Cayman,
Cayman Islands
|
-$1.79M |
| 5 |
CM
Crestline Management
Fort Worth,
Texas
|
-$660K |